Seasonal Affective Disorder Therapeutics Market Outlook (2022-2028)
[216 Pages] From 2022 to 2028, the global seasonal affective disorder therapeutics market is slated to rise at a CAGR of 4.3%. Currently, the market accounts for a valuation of US$ 848.2 Mn, and is projected to close in on US$ 1.1 Bn by the end of 2028.
Sales of seasonal affective disorder therapeutic drugs and devices account for a share of 4.6% in the global depressive disorder treatment market. Preference and popularity of bright light therapy among physicians and patients is expected to be a major trend driving seasonal affective disorder therapeutics demand growth through 2028.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
4.29%
H1, 2022 Projected
4.34%
H1, 2022 Outlook
4.24%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 10 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(-) 05 ↓
The market for seasonal affective disorder therapeutics is subject to change as per the regulatory dynamics for drugs, in accordance to macroeconomic and industrial standards.
The variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline of 10 BPS units. Additionally, a drop in BPS growth in H1-2022 over H1-2021 by 05 Basis Point Share (BPS) is demonstrated by the market.
The decline in the BPS values is associated with the limited evidence for the effectiveness of light therapy when compared with other available preventive options. Moreover, patient preference towards treatment modalities is dominant for the preventive treatment of seasonal affective disorder.
On the contrary, the market is expected to gain traction in terms of growth and sales outlook during the forecast period. This is supported with the development of second-generation antidepressants for the treatment of seasonal affective disorder in adults.
The key developments in the market include the FDA approval of an extended-release antidepressant, bupropion, for the prevention of recurrent seasonal affective disorder with major depressive episodes.
Demand Survey of Seasonal Affective Disorder Therapeutics (2013 to 2021) Vs Market Statistics (2022 to 2028)
Anxiety and depression among the general population have seen a substantial spike over the past few years and this has majorly influenced the healthcare industry in multiple ways. The seasonal affective disorder therapeutics market exhibited expansion at a CAGR of 3.7% from 2013 to 2021.
Increasing prevalence of seasonal affective disorders, rising instances of depression among the general population, increasing availability of treatment options, and rising research and development activities in therapeutics are some major factors that are anticipated to influence seasonal affective disorder therapeutics demand over the forecast period.
Research & development activities are of paramount importance in helping create effective therapeutic solutions for seasonal affective disorders. Seasonal affective disorder therapeutic providers are focusing on expanding their research scope and creating novel therapeutic solutions for patients.
For instance, in April 2021, researchers at the Indiana University School of Medicine published a new study that indicates promising results of blood tests to detect bipolar disorders and depression. This study, led by Dr. Alexander B. Niculescu, is expected to offer a promising scope of precision medicine and personalized treatment for patients.
Demand for seasonal affective disorder therapeutics is estimated to rise at a CAGR of 4.3% from 2022 to 2028.
What Market Factors Could Seasonal Affective Disorder Therapeutic Providers Benefit From?
“Increasing Popularity of Light Therapy to Positively Impact Market Potential”
Bright light therapy has emerged as one of the most popular aspects of the seasonal affective disorder therapeutics marketplace in recent years. This therapy provides a rapid anti-depressant effect on patients and has seen an increase in recommendation by physicians and health professionals.
For instance, in July 2021, researchers at the University of Fribourg published a study in the PLOS Genetics journal and depicted effects of light therapy on depression in mice models. Activation of circadian clock gene Period1 in the mood-affecting region of the brain was found to help treat depression, in this study by Urs Albrecht.
Find your sweet spots for generating winning opportunities in this market.
What is Negatively Affecting Demand for Seasonal Affective Disorder Therapeutic Devices?
“Lack of Research Data & Adverse Effects of Anti-depressants to Majorly Hamper Market Growth”
Scarce research data and low availability of information on seasonal affective disorders are anticipated to be major barriers for seasonal affective disorder therapeutics providers. Inadequate research data on effects of bright light and blue light on the treatment of patients is expected to restrain market potential.
Adverse effects associated with excessive use of anti-depressants and other therapy drugs are predicted to be a major issue in the seasonal affective disorder therapeutics industry landscape over the forecast period.
What is the Regional Outlook for Seasonal Affective Disorder Therapeutic Companies?
“North America to Exhibit Highly Lucrative Opportunities through 2028”
Statistical analysis of seasonal affective disorder therapeutics market metrics for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been assessed in this market study.
Accounting for a dominative market share of 38.4% in the global seasonal affective disorder therapeutics marketplace, North America is anticipated to provide a highly beneficial setting for seasonal affective disorder therapeutic companies. Increasing prevalence of seasonal affective disorders and rising focus on healthcare are expected to be major trends in this region.
Second to North America, the Europe seasonal affective disorder therapeutics product market accounts for a market share of 29.5% in 2022. Increasing healthcare expenditure and rising research and development activities for seasonal affective disorders are expected to be prominent trends in this region through 2028.
Rising awareness about anxiety and depression is expected to majorly boost awareness about seasonal affective disorders in regions of East Asia and South Asia. Currently, East Asia and South Asia account for market shares of 18.5% and 7.5% in the global seasonal affective disorder therapeutics market.
Lack of awareness, low research activity, and underdeveloped healthcare infrastructure are expected to lead to slow growth in seasonal affective disorder therapeutics demand in regions of Oceania and the MEA. At present, the MEA and Oceania regions hold market shares of 1.5% and 1%, respectively, in the global seasonal affective disorder therapeutics industry.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Analysis
What is the Outlook for Seasonal Affective Disorder Therapeutic Device Manufacturers in India?
“Rising Awareness & Focus on Mental Health Expected to Positively Impact Market Expansion”
Mental health has emerged as one of the most concerning healthcare issues in India over the past few years and this has also bolstered demand for multiple seasonal affective disorder treatments. Developing healthcare infrastructure, lack of awareness, and lack of availability of treatments are expected to be prominent trends controlling demand for seasonal affective disorder therapeutics in India.
How Will the U.S. Seasonal Affective Disorder Therapeutics Market Fare?
“High Prevalence of Multiple Seasonal Affective Disorders to Positively Influence Demand”
The U.S. has seen a substantial increase in instances of anxiety and depression-related disorders and this has fostered a demand for seasonal affective disorder therapeutics. Rising instances of bipolar disorders is the major trend that drives the market potential for this nation.
High research & development activities and increasing availability of treatment options are also expected to favor seasonal affective disorder therapeutics demand.
Seasonal affective disorder therapeutic providers are focusing on developing and launching novel treatment solutions to maximize their revenue potential in the nation.
Category-wise Analysis
What Influence Does Bipolar Disorder Have on This Market?
“High Incidence of Bipolar Disorders to Majorly Govern Seasonal Affective Disorder Therapeutics Demand”
Bipolar disorder has emerged as one of the most prominent seasonal affective disorders over recent years and this has led to its substantial influence on the seasonal affective disorder therapeutics marketplace.
This disorder is expected to hold a dominant market share over the forecast period and is expected to be a majorly influential segment through 2028.
COVID-19 Impact Survey
The unexpected and sudden emergence of the COVID-19 pandemic adversely affected the mental health of people all over the globe and led to an increase in anxiety and depression in individuals.
While the seasonal affective disorder therapeutics market saw a negative growth trend in 2020 due to disruptions to supply chains and lockdown mandates, the seasonal affective disorder therapeutics market is expected to see high demand in the post-pandemic era.
Competitive Landscape
Seasonal affective disorder therapeutic providers are investing in the research & development of novel therapeutics specific to seasonal affective disorders. Seasonal affective disorder therapeutic equipment manufacturing companies are also adopting organic and inorganic strategies to increase awareness about seasonal affective disorders and boost their sales revenue.
For instance, in December 2021, the U.S. Food and Drug Administration (FDA) cleared a new drug that would be used in treating bipolar depression. The drug Caplyta (lumateperone) created by a pharmaceutical company called Intra-Cellular Therapies, has been approved to treat depressive episodes that are resulted from bipolar I or bipolar II disorders in adults.
As it is the first FDA-approved drug of its kind, it is expected to see high demand over the coming years.
Seasonal Affective Disorder Therapeutics Industry Report Scope
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Monoamine Oxidase Inhibitors (MAOIs)
Tricyclic Antidepressants (TCAs)
Seasonal Affective Disorder Therapeutic Devices
Light Boxes
Dawn Stimulators
Desk Lamps
Sun Visors
Seasonal Affective Disorder Therapeutics Market by Disorder Type:
Seasonal Affective Disorder Therapeutics for Unipolar Disorders
Fall-Winter Onset
Spring-Summer Onset
Seasonal Affective Disorder Therapeutics for Bipolar Disorders
Seasonal Affective Disorder Therapeutics Market by Distribution Channel:
Institutional Sales
Seasonal Affective Disorder Therapeutics for Hospitals
Seasonal Affective Disorder Therapeutics for Clinics
Seasonal Affective Disorder Therapeutics for Wellness Centres & Spas
Retail Sales
Retail Pharmacies
Drug Stores
Online Sales
Seasonal Affective Disorder Therapeutics Market by Region:
North America Seasonal Affective Disorder Therapeutics Market
Latin America Seasonal Affective Disorder Therapeutics Market
Europe Seasonal Affective Disorder Therapeutics Market
East Asia Seasonal Affective Disorder Therapeutics Market
South Asia & Pacific Seasonal Affective Disorder Therapeutics Market
Middle East & Africa (MEA) Seasonal Affective Disorder Therapeutics Market
Frequently Asked Questions
The global seasonal affective disorder therapeutics market is anticipated to attain a valuation of US$ 1.1 Bn by the end of 2028.
Key suppliers of seasonal affective disorder therapeutic systems are F. Hoffman-La Roche AG, Mylan N.V., Sanofi AG, Novartis AG, Janssen Pharmaceuticals Inc., Koninklije Philips N.V., and The Sunbox Company.
Currently, the North America seasonal affective disorder therapeutics market holds a prominent share of 38.4% in the global industry.
From 2022 to 2028, the seasonal affective disorder therapeutics market is predicted to expand at a CAGR of 4.3%.
In 2022, the seasonal affective disorder therapeutics market accounts for a value of US$ 848.2 Mn.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.2. Forecast Factors - Relevance & Impact
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Trends
4. Key Success Factors
4.1. Key Regulations
4.2. Disease Epidemiology
5. Global Seasonal Affective Disorder Therapeutics Market Volume Analysis 2013-2021 and Forecast, 2022-2028
5.1. Historical Market Volume (‘000 Units) Analysis, 2013-2021
5.2. Current and Future Market Volume (‘000 Units) Projections, 2022-2028
6. Global Seasonal Affective Disorder Therapeutics Market - Pricing Analysis
6.1. Regional Pricing Analysis By Device Type
6.2. Global Average Pricing Analysis Benchmark
7. Global Seasonal Affective Disorder Therapeutics Market Value Analysis 2013-2021 and Forecast, 2022-2028
7.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Treatment Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013 - 2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2022 – 2022
8.3.1. Drugs
8.3.1.1. Selective serotonin reuptake inhibitors (SSRIs)
8.3.1.2. Norepinephrine-dopamine reuptake inhibitor (NDRI)
8.3.1.3. Serotonin and norepinephrine reuptake inhibitors (SNRIs)
8.3.1.4. Monoamine oxidase inhibitors (MAOIs)
8.3.1.5. Tricyclic antidepressants (TCAs)
8.3.2. Devices
8.3.2.1. Light Boxes
8.3.2.2. Dawn Stimulators
8.3.2.3. Desk Lamps
8.3.2.4. Sun Visors
8.4. Market Attractiveness Analysis By Treatment Type
9. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Disorder Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Disorder Type, 2013 - 2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disorder Type, 2022 - 2022
9.3.1. Unipolar Disorder
9.3.1.1. Fall-winter onset
9.3.1.2. Spring-summer onset
9.3.1.2. Bipolar Disorder
9.4. Market Attractiveness Analysis By Sales Channel
10. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2022
10.3.1. Institutional Sales
10.3.1.1. Hospitals
10.3.1.2. Clinics
10.3.1.3. Wellness Centers & Spas
10.3.2. Retail Sales
10.3.2.1. Retail Pharmacies
10.3.2.2. Drug Stores
10.3.2.3. Online Sales
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2022
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Middle East and Africa (MEA)
11.3.5. East Asia
11.3.6. South Asia
11.3.7. Oceania
11.4. Market Attractiveness Analysis By Region
12. North America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Treatment Type
12.3.3. By Disorder Type
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
13. Latin America Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Treatment Type
13.3.3. By Disorder Type
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
14. Europe Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. Russia
14.3.1.7. Rest of Europe
14.3.2. By Treatment Type
14.3.3. By Disorder Type
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
15. South Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Treatment Type
15.3.3. By Disorder Type
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
16. East Asia Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Treatment Type
16.3.3. By Disorder Type
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
17. Oceania Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Treatment Type
17.3.3. By Disorder Type
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
18. Middle East and Africa Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2028
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. South Africa
18.3.1.3. Rest of Middle East and Africa
18.3.2. By Treatment Type
18.3.3. By Disorder Type
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
19. Emerging Countries Seasonal Affective Disorder Therapeutics Market Analysis 2013-2021 and Forecast 2022-2028
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. China Seasonal Affective Disorder Therapeutics Market Analysis
19.2.1. Introduction
19.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.2.2.1. By Treatment Type
19.2.2.2. By Disorder Type
19.2.2.3. By Distribution Channel
19.3. Russia Seasonal Affective Disorder Therapeutics Market Analysis
19.3.1. Introduction
19.3.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.3.2.1. By Treatment Type
19.3.2.2. By Disorder Type
19.3.2.3. By Distribution Channel
19.4. Indonesia Seasonal Affective Disorder Therapeutics Market Analysis
19.4.1. Introduction
19.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.4.2.1. By Treatment Type
19.4.2.2. By Disorder Type
19.4.2.3. By Distribution Channel
19.4.3. Russia Seasonal Affective Disorder Therapeutics Market - Competition Landscape
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Allergan plc
20.2.1.1. Overview
20.2.1.2. Product Portfolio
20.2.1.3. Analyst Commentary
20.2.1.4. Key Financials
20.2.1.5. Strategy Overview
20.2.2. Eli Lily Company
20.2.3. GlaxoSmithKline
20.2.4. Pfizer Inc.
20.2.5. Teva Pharmaceuticals
20.2.6. Bausch Health Companies Inc.
20.2.7. F. Hoffmann-La Roche AG
20.2.8. Mylan N.V.
20.2.8.1. Sanofi AG
20.2.9. Novartis AG
20.2.10. Janssen Pharmaceuticals, Inc.
20.2.11. Koninklijke Philips N.V
20.2.12. The Sunbox Company
20.2.13. Beurer GmbH
20.2.14. Lucimed S.A.
21. Assumptions and Acronyms Used22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type
Table 02: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Treatment Type
Table 03: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Disorder Type
Table 04: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Distribution Channel
Table 05: Global Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis and Opportunity Assessment 2013–2028, By Region
Table 06: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country
Table 07: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 08: North America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 09: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 10: North America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 11: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country
Table 12: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 13: Latin America Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 14: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 15: Latin America Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 16: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country
Table 17: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 18: Europe Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 19: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 20: Europe Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 21: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country
Table 22: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 23: South Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 24: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 25: South Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 26: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country
Table 27: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 28: East Asia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 29: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 30: East Asia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 31: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country
Table 32: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 33: Oceania Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 34: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 35: Oceania Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 36: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Country
Table 37: Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 38: MEA Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 39: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 40: MEA Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 41: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 42: China Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 43: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 44: China Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 45: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 46: Russia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 47: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 48: Russia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Table 49: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Treatment Type
Table 50: Indonesia Seasonal Affective Disorder Therapeutics Market Volume (‘000 Units) Analysis 2013-2017 and Forecast 2018–2028, By Device Type
Table 51: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Disorder Type
Table 52: Indonesia Seasonal Affective Disorder Therapeutics Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018–2028, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Seasonal Affective Disorder Therapeutics Market Volume Analysis (‘000 Units), By Devices, 2013-2017
Figure 02: Global Seasonal Affective Disorder Therapeutics Market Volume Forecast (‘000 Units), By Devices, 2018-2028
Figure 03: Light Boxes, Pricing Analysis per unit (US$), By Region, 2017
Figure 04: Light Boxes, Pricing Analysis per unit (US$), By Region, 2028
Figure 05: Dawn Stimulator, Pricing Analysis per unit (US$), By Region, 2017
Figure 06: Dawn Stimulator, Pricing Analysis per unit (US$), By Region, 2028
Figure 07: Desk Lamp, Pricing Analysis per unit (US$), By Region, 2017
Figure 08: Desk Lamp, Pricing Analysis per unit (US$), By Region, 2028
Figure 09: Sun Visors , Pricing Analysis per unit (US$), By Region, 2017
Figure 10: Sun Visors , Pricing Analysis per unit (US$), By Region, 2028
Figure 11: Global Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 12: Global Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 13: Global Seasonal Affective Disorder Therapeutics Market Absolute $ Opportunity, 2018 - 2028
Figure 14: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Treatment Type, 2018 & 2028
Figure 15: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Treatment Type, 2018-2028
Figure 16: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 17: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Disorder Type, 2018 & 2028
Figure 18: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Disorder Type, 2018-2028
Figure 19: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 20: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Distribution Channel, 2018 & 2028
Figure 21: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2028
Figure 22: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 23: Global Seasonal Affective Disorder Therapeutics Market Share Analysis (%), By Region, 2018 & 2028
Figure 24: Global Seasonal Affective Disorder Therapeutics Market Y-o-Y Analysis (%), By Region, 2018-2028
Figure 25: Global Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Region, 2018-2028
Figure 26: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)
Figure 27: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)
Figure 28: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)
Figure 29: North America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)
Figure 30: North America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 31: North America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 32: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 33: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 34: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 35: North America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028
Figure 36: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)
Figure 37: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)
Figure 38: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)
Figure 39: Latin America Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)
Figure 40: Latin America Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 41: Latin America Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 42: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 43: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 44: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 45: Latin America Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028
Figure 46: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)
Figure 47: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)
Figure 48: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)
Figure 49: Europe Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)
Figure 50: Europe Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 51: Europe Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 52: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 53: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 54: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 55: Europe Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028
Figure 56: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)
Figure 57: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)
Figure 58: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)
Figure 59: South Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)
Figure 60: South Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 61: South Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 62: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 63: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 64: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 65: South Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028
Figure 66: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)
Figure 67: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)
Figure 68: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)
Figure 69: East Asia Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)
Figure 70: East Asia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 71: East Asia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 72: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 73: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 74: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 75: East Asia Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028
Figure 76: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)
Figure 77: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)
Figure 78: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)
Figure 79: Oceania Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)
Figure 80: Oceania Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 81: Oceania Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 82: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 83: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 84: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 85: Oceania Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028
Figure 86: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Treatment Type (2018 E)
Figure 87: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Disorder Type (2018 E)
Figure 88: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Distribution Channel (2018 E)
Figure 89: MEA Seasonal Affective Disorder Therapeutics Market Value Share, By Country (2018 E)
Figure 90: MEA Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 91: MEA Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 92: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Treatment Type, 2018-2028
Figure 93: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Disorder Type, 2018-2028
Figure 94: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Distribution Channel, 2018-2028
Figure 95: MEA Seasonal Affective Disorder Therapeutics Market Attractiveness Analysis by Country, 2018-2028
Figure 96: Global Seasonal Affective Disorder Therapeutics Market Value Proportion Analysis, By Emerging Countries, 2018
Figure 97: Seasonal Affective Disorder Therapeutics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2018-2028
Figure 98: China Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 99: China Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 100: Russia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 101: Russia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
Figure 102: Indonesia Seasonal Affective Disorder Therapeutics Market Value Analysis (US$ Mn), 2013-2017
Figure 103: Indonesia Seasonal Affective Disorder Therapeutics Market Value Forecast (US$ Mn), 2018-2028
